Ocumen Bio-B
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Ocumen Bio-B
Ocumension Biopharma is a China-based holding company primarily engaged in the discovery, development, and commercialization of ophthalmic therapeutics. Its key products include OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101, and OT-202. The company conducts business in China. The company's address is: No. 1858, Yinzhong South Road, Guoxiang Street, Wuzhong District, Suzhou City, Jiangsu Province, China.
How to Buy Ocumen Bio-B (01477.HK)
Sign In
1-Minute Account Opening
Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.
Deposit funds
Once your account has been verified, you can deposit funds into your account using your preferred payment method.
Buy 01477.HK
Search for 01477.HK via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.